| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.912975 |
| 003 | CaOODSP |
| 005 | 20221107182702 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 220630t20222022onc o f000 0 eng d |
| 020 | |a9780660443614 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP40-314/1-2022E-PDF |
| 245 | 00|aPrioritization guide for assessing the need for economic evidence. |
| 250 | |aVersion 1.0 |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022. |
| 264 | 4|c©2022 |
| 300 | |a1 online resource (9 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |a"February 2022." |
| 500 | |a"Protecting and empowering Canadians to improve their health." |
| 500 | |aAt head of title: National Advisory Committee on Immunization (NACI). |
| 500 | |aIssued also in French under title: Guide sur l'établissement des priorités relatives aux données économiques. |
| 520 | |a"User guide: Burden of disease -- Proposed benefit -- Overall assessment of need for economic evidence"--Pages 7-8. |
| 650 | 0|aVaccination|xEconomic aspects|zCanada. |
| 650 | 0|aVaccines|xEconomic aspects|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tGuide sur l'établissement des priorités relatives aux données économiques.|w(CaOODSP)9.912974 |
| 856 | 40|qPDF|s241 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-314-1-2022-eng.pdf |
| 986 | |a220249 |